EMA issues Questions and Answers on the use of phosphates in eye drops

Source: European Medicines Agency
Area: News
The European Medicines Agency (EMA) has completed an assessment of the use of phosphate buffers in medicinal products given as eye drops and examined whether these can cause corneal calcification. The Agency's Committee for Medicinal Products for Human Use (CHMP) considered that the benefits of phosphate-containing eye drops outweigh their risks but that in very rare cases patients with significant damage to the cornea may develop corneal calcification during treatment with eye drops that contain phosphate, and that this should be mentioned in the (Read more...)

Full Story →